New hope for the prevention of recurrent atrial fibrillation

被引：14

作者：

Abdelhadi, RH ^{[1
]}

Chung, MK ^{[1
]}

Van Wagoner, DR ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

来源：

EUROPEAN HEART JOURNAL | 2004年 / 25卷 / 13期

关键词：

D O I：

10.1016/j.ehj.2004.04.035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1089 / 1090

页数：2

共 11 条

[1] Inflammation as a risk factor for atrial fibrillation [J].

Aviles, RJ ;

Martin, DO ;

Apperson-Hansen, C ;

Houghtaling, PL ;

Rautaharju, P ;

Kronmal, RA ;

Tracy, RP ;

Van Wagoner, DR ;

Psaty, BM ;

Lauer, MS ;

Chung, MK .

CIRCULATION, 2003, 108 (24) :3006-3010

[2]

Bruins P, 1997, CIRCULATION, V96, P3542

[3] C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation [J].

Chung, MK ;

Martin, DO ;

Sprecher, D ;

Wazni, O ;

Kanderian, A ;

Carnes, CA ;

Bauer, JA ;

Tchou, PJ ;

Niebauer, MJ ;

Natale, A ;

Van Wagoner, DR .

CIRCULATION, 2001, 104 (24) :2886-2891

[4] Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation [J].

Dernellis, J ;

Panaretou, M .

EUROPEAN HEART JOURNAL, 2004, 25 (13) :1100-1107

[5] C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation [J].

Dernellis, J ;

Panaretou, M .

ACTA CARDIOLOGICA, 2001, 56 (06) :375-380

[6] The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model [J].

Kumagai, K ;

Nakashima, H ;

Saku, K .

CARDIOVASCULAR RESEARCH, 2004, 62 (01) :105-111

[7] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial [J].

Nissen, SE ;

Tuzcu, EM ;

Schoenhagen, P ;

Brown, BG ;

Ganz, P ;

Vogel, RA ;

Crowe, T ;

Howard, G ;

Cooper, CJ ;

Brodie, B ;

Grines, CL ;

DeMaria, AN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1071-1080

[8]

Ridker PM, 1998, J INVEST MED, V46, P391

[9] Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events [J].

Ridker, PM ;

Shih, J ;

Cook, TJ ;

Clearfield, M ;

Downs, JR ;

Pradhan, AD ;

Weis, SE ;

Gotto, AM .

CIRCULATION, 2002, 105 (15) :1776-1779

[10]

VANWAGONER DR, 2003, CLEVE CLIN J MED S3, V70, P52

← 1 2 →